109451
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
右美托咪定鼻喷雾剂对腹腔镜妇科手术患者术后睡眠质量的影响：一项单中心、双盲、随机对照研究
Authors Fan K, Ma J, Liu W, Chen X
Received 7 June 2025
Accepted for publication 3 October 2025
Published 15 October 2025 Volume 2025:19 Pages 9291—9302
DOI https://doi.org/10.2147/DDDT.S545452
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Tin Wui Wong
Keke Fan,1 Junyi Ma,2 Wenxing Liu,2 Xi Chen3
1Department of Anesthesiology, Shenzhen Children’s Hospital, Shenzhen, Guangdong Province, People’s Republic of China; 2Department of Anesthesiology, Guangzhou Women and Children’s Medical Center, Guangzhou, Guangdong Province, People’s Republic of China; 3Department of Anesthesiology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong Province, People’s Republic of China
Correspondence: Xi Chen, Email 877579351@qq.com
Background: Dexmedetomidine nasal sprays is effective for perioperative sedation, analgesia, and anxiolysis. Nevertheless, its impact on postoperative sleep quality along with the optimal dosage and overall efficacy remains unclear in patients undergoing laparoscopic gynecological surgery.
Methods: A total of 150 adult patients undergoing laparoscopic gynecological surgery were enrolled, with 144 included in the final analysis. Patients in the dexmedetomidine (Dex) group received 50 μg of intranasal dexmedetomidine 30 minutes before sleep on the first postoperative night, while the control group received an equivalent volume of saline. Primary outcomes included objective sleep parameters (sleep duration, deep sleep duration, REM sleep duration and light sleep duration) measured via a portable sleep monitor, as well as subjective sleep parameters assessed by Athens Insomnia Scale (AIS) and Numerical Rating Scale (NRS) scores one night before and on the first night after surgery. Secondary outcomes comprised postoperative pain measured by VAS, nausea and vomiting, and average heart rate.
Results: The sleep duration, deep sleep duration and REM sleep duration of patients in the control group decreased after laparoscopic gynaecological surgery (vs preoperative control group, P=0.021, P< 0.001, P=0.005, respectively), whereas the fragmented sleep duration and NRS score increased (vs preoperative control group, P=0.017, P=0.032, respectively) . In contrast, those treated with dexmedetomidine (Dex group) exhibited significantly improved sleep quality postoperatively, with greater sleep duration, deep sleep duration, and REM sleep durations (vs control group, P< 0.001, P< 0.001, P< 0.001, respectively). There were no significant differences in postoperative pain or nausea and vomiting between the two groups.
Conclusion: Dexmedetomidine nasal sprays improved postoperative sleep quality in patients who underwent laparoscopic gynaecological surgery.
Trial Registration: Chinese Clinical Trial Registry (clinical trial number: ChiCTR2400080181).
Keywords: dexmedetomidine, nasal sprays, sleep disturbance, gynaecological surgery
1Department of Anesthesiology, Shenzhen Children’s Hospital, Shenzhen, Guangdong Province, People’s Republic of China; 2Department of Anesthesiology, Guangzhou Women and Children’s Medical Center, Guangzhou, Guangdong Province, People’s Republic of China; 3Department of Anesthesiology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong Province, People’s Republic of China
Correspondence: Xi Chen, Email 877579351@qq.com
Background: Dexmedetomidine nasal sprays is effective for perioperative sedation, analgesia, and anxiolysis. Nevertheless, its impact on postoperative sleep quality along with the optimal dosage and overall efficacy remains unclear in patients undergoing laparoscopic gynecological surgery.
Methods: A total of 150 adult patients undergoing laparoscopic gynecological surgery were enrolled, with 144 included in the final analysis. Patients in the dexmedetomidine (Dex) group received 50 μg of intranasal dexmedetomidine 30 minutes before sleep on the first postoperative night, while the control group received an equivalent volume of saline. Primary outcomes included objective sleep parameters (sleep duration, deep sleep duration, REM sleep duration and light sleep duration) measured via a portable sleep monitor, as well as subjective sleep parameters assessed by Athens Insomnia Scale (AIS) and Numerical Rating Scale (NRS) scores one night before and on the first night after surgery. Secondary outcomes comprised postoperative pain measured by VAS, nausea and vomiting, and average heart rate.
Results: The sleep duration, deep sleep duration and REM sleep duration of patients in the control group decreased after laparoscopic gynaecological surgery (vs preoperative control group, P=0.021, P< 0.001, P=0.005, respectively), whereas the fragmented sleep duration and NRS score increased (vs preoperative control group, P=0.017, P=0.032, respectively) . In contrast, those treated with dexmedetomidine (Dex group) exhibited significantly improved sleep quality postoperatively, with greater sleep duration, deep sleep duration, and REM sleep durations (vs control group, P< 0.001, P< 0.001, P< 0.001, respectively). There were no significant differences in postoperative pain or nausea and vomiting between the two groups.
Conclusion: Dexmedetomidine nasal sprays improved postoperative sleep quality in patients who underwent laparoscopic gynaecological surgery.
Trial Registration: Chinese Clinical Trial Registry (clinical trial number: ChiCTR2400080181).
Keywords: dexmedetomidine, nasal sprays, sleep disturbance, gynaecological surgery